|
|
|
|
|
by missedthecue
19 days ago
|
|
"So you have on one end the token revenue trending down, on the other end the training cost going up for the next frontier models, and you need to pay back your 10y debt." Not necessarily, the bond holders could simply take a massive hair cut and lose shitloads of money. On the topic of bubbles and exuberance, Jeff Bezos made the salient point that there was a massive over-invested biotech boom in the 1990s and tons of sophisticated investors ended up losing lots of money. But humanity still kept the medical advancements made by the boom. Stocks going down didn't un-research drugs, and it won't un-research new GPUs or un-build datacenters. |
|
Drugs cost pennies to manufacture after they are researched and make their way through the approval pipeline. There are many generic drug manufacturers who can work off the existing formulas.
The more apt comparison is that LLMs won't be un-trained. Opus 4.8 now exists. Even if Anthropic somehow went bankrupt, that particular asset could, at the very least, be sold for proverbial pennies on the dollar to a "generic" inference provider.